Lin Tuo
Impact in
- Hepatology top 10%
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Metabolism, Diabetes, and Cancer 2
- Glutathione Transferases and Polymorphisms 1
- Glycosylation and Glycoproteins Research 1
- Ubiquitin and proteasome pathways 1
-
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Ni Tang (5 shared papers)Xuanming Pan (4 shared papers)Kai Wang (5 shared papers)Ailong Huang (3 shared papers)Xiang Jin (4 shared papers)Li Liang (4 shared papers)Jie Xia (4 shared papers)Chang Chen (3 shared papers)
- Journals
- Medicine (1 paper)Frontiers in Endocrinology (1 paper)Frontiers in Immunology (1 paper)Frontiers in Oncology (1 paper)Anesthesia & Analgesia (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Lin Tuo
21 papers receiving 479 citations
Lin Tuo's Hit Papers
Peers
Comparison fields: 5 of 86
- Hepatology 49
- Cancer Research 85
- Epidemiology 124
- Virology 17
- Molecular Biology 173
Countries citing papers authored by Lin Tuo
This map shows the geographic impact of Lin Tuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Tuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Tuo more than expected).
Fields of papers citing papers by Lin Tuo
This network shows the impact of papers produced by Lin Tuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Tuo. The network helps show where Lin Tuo may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Tuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice Hit paper breakdown → | 2023 | 105 |
| 2 | 2021 | 90 | |
| 3 | 2022 | 72 | |
| 4 | 2019 | 62 | |
| 5 | 2018 | 42 | |
| 6 | 2023 | 33 | |
| 7 | 2023 | 15 | |
| 8 | 2018 | 13 | |
| 9 | 2021 | 13 | |
| 10 | Shale Gas and Its Significance for Exploration | 2008 | 12 |
| 11 | 2019 | 8 | |
| 12 | 2017 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2017 | 3 | |
| 15 | 2022 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2025 | 1 | |
| 18 | 2017 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2024 | 1 |
About Lin Tuo
Lin Tuo is a scholar working on Molecular Biology, Epidemiology, Surgery, Information Systems and Mechanics of Materials, having authored 24 papers that have together received 485 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (3 papers), Hydrocarbon exploration and reservoir analysis (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Glutathione Transferases and Polymorphisms (1 paper), Glycosylation and Glycoproteins Research (1 paper), Coal Properties and Utilization (1 paper), Ubiquitin and proteasome pathways (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Hepatology (49 citations), Cancer Research (85 citations), Epidemiology (124 citations), Virology (17 citations) and Molecular Biology (173 citations). Lin Tuo has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Ni Tang, Xuanming Pan, Kai Wang, Ailong Huang, Xiang Jin, Li Liang, Jie Xia, Chang Chen, Haijun Deng and Guiji Zhang. Their work appears in journals such as Medicine, Frontiers in Endocrinology, Frontiers in Immunology, Frontiers in Oncology and Anesthesia & Analgesia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.